Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | DHFR | P00374 | 14/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | TYMS | P04818 | 2/20 | 0.36 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.36 |
| ▸ | MAPK9 | P45984 | 2/20 | 0.36 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.36 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.34 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10050414 | 0.90 | PIK3R1 (0.39) | KDM4EDHFRMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL10050413 | 0.90 | PIK3R1 (0.39) | KDM4EDHFRMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL10050415 | 0.88 | PIK3R1 (0.42) | KDM4EMAPK8MAPK9MAPK10PIK3R1 | |
| SCHEMBL10050418 | 0.87 | MAPT (0.39) | KDM4EDHFRMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL10050430 | 0.85 | PIK3R1 (0.36) | MAPTRAB9ASMN1; SMN2MAPK8MAPK9 | |
| SCHEMBL10050406 | 0.81 | ADORA2A (0.45) | KDM4EMAPTMAPK9 | |
| SCHEMBL10050405 | 0.81 | RORB (0.35) | SMN1; SMN2 | |
| SCHEMBL10050416 | 0.80 | PIK3R1 (0.42) | DHFRMAPTRAB9ASMN1; SMN2TYMS | |
| SCHEMBL10074361 | 0.80 | KDM4E (0.48) | KDM4EDHFRMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL10050427 | 0.78 | TP53 (0.37) | MAPTRAB9ASMN1; SMN2MAPK8MAPK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8119828-B2 | Material for an organic electroluminescence device and an organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2012-02-21 | — | — | US | disclosed |
| US-20100044686-A1 | MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100044686-A1 | MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE | AFF4, KCNH3, HCN4 | KDM4E 573/4885DHFR 3591/4885MAPT 4038/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.